74 related articles for article (PubMed ID: 6088045)
1. Effect of frequency of administration on therapeutic efficacy of cefotaxime.
Parker RH
Clin Ther; 1984; 6(4):488-99. PubMed ID: 6088045
[TBL] [Abstract][Full Text] [Related]
2. Limiting cefotaxime pediatric dosing to adult standards: a pharmacokinetic simulation study.
Dulaney Lopez AM; Rodriguez JC; Lopez-Samblas AM; Estes KS
Int J Clin Pharmacol Ther; 1999 Jun; 37(6):269-74. PubMed ID: 10395117
[TBL] [Abstract][Full Text] [Related]
3. Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
Moore RD; Smith CR; Holloway JJ; Lietman PS
Arch Intern Med; 1986 Jun; 146(6):1153-7. PubMed ID: 3087307
[TBL] [Abstract][Full Text] [Related]
4. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
5. Carbapenems: monotherapy in intra-abdominal sepsis.
Wilson SE
Scand J Infect Dis Suppl; 1995; 96():28-33. PubMed ID: 7652500
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ceftizoxime administered twice daily in hospitalized patients with respiratory tract infections.
Lentnek A; Wikler M; McDevitt J; Sohn C
Clin Ther; 1984; 7(1):33-9. PubMed ID: 6097357
[TBL] [Abstract][Full Text] [Related]
7. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study.
Rimola A; Salmerón JM; Clemente G; Rodrigo L; Obrador A; Miranda ML; Guarner C; Planas R; Solá R; Vargas V
Hepatology; 1995 Mar; 21(3):674-9. PubMed ID: 7875666
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. Review and reassessment of dosing schedules for cefotaxime in selected medical indications.
Young LS
Diagn Microbiol Infect Dis; 1995; 22(1-2):147-54. PubMed ID: 7587030
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options for cefotaxime in the management of bacterial infections.
Raddatz JK; Ostergaard BE; Rotschafer JC
Diagn Microbiol Infect Dis; 1995; 22(1-2):77-83. PubMed ID: 7587054
[TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone versus combined gentamicin and clindamycin for polymicrobial surgical sepsis.
Stone HH; Mullins RJ; Strom PR; Bourneuf AA; Geheber CE
Am J Surg; 1984 Oct; 148(4A):30-4. PubMed ID: 6091478
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
14. Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.
Brogden RN; Spencer CM
Drugs; 1997 Mar; 53(3):483-510. PubMed ID: 9074846
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes and cost minimization with an alternative dosing regimen for meropenem in a community hospital.
Patel GW; Duquaine SM; McKinnon PS
Pharmacotherapy; 2007 Dec; 27(12):1637-43. PubMed ID: 18041884
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic prophylaxis in genitourinary surgery: a comparison of cefotaxime and cefazolin.
Childs SJ; Wood PD; Kosola JW
Clin Ther; 1982; 5 Suppl A():48-57. PubMed ID: 6293717
[TBL] [Abstract][Full Text] [Related]
17. [Use of cefotaxime in severe infections in newborn infants].
Peskine F; Astruc J; Rodiére M; Echenne B; Brunel D
Pathol Biol (Paris); 1984 Dec; 32(10):1040-2. PubMed ID: 6096793
[TBL] [Abstract][Full Text] [Related]
18. Cefotaxime treatment of skin and skin structure infections: a multicenter study.
LeFrock JL; McCloskey RV
Clin Ther; 1982; 5 Suppl A():19-25. PubMed ID: 6293714
[TBL] [Abstract][Full Text] [Related]
19. Clinical comparison of cefotaxime versus the combination of gentamicin plus clindamycin in the treatment of polymicrobial soft-tissue surgical sepsis.
Strom PR; Geheber CE; Morris ES; Stone HH
Clin Ther; 1982; 5 Suppl A():26-31. PubMed ID: 6293715
[TBL] [Abstract][Full Text] [Related]
20. Ceftriaxone therapy of meningitis and serious infections.
Steele RW
Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
